Using nanoscale chromatin profiling in the same HCC tissues, we minimized ambiguity in enhancer localization and confirmed specific enhancer hypomethylation-associated C/EBPβ over-expression using bisulfite pyrosequencing and qRT-PCR in ~100 HCC tumor/non-tumor tissues. The gene discussed is CEBPB; the disease is hepatocellular carcinoma.